Lupin Bioresearch Center (LBC), started in early 2009, has both Clinical and Bioanalytical capabilities. This independent center in Pashan, Pune, houses 2 clinics, a bioanalytical lab with 8 state-of-the-art LC/MS-MS systems and its own clinical chemistry lab amongst several other capabilities.

LBC underwent a successful US FDA inspection in October 2010 for both the Bioanalytical and Clinical areas and the center was commended by the agency inspectors for their excellent practices and systems.

LBC conducts important bioequivalence testing exclusively for Lupin’s generic products prior to the filing of our ANDAs or other regulated market filings. LBC also manages out-sourced Bio-Equivalence studies, clinical end-point studies as well as the studies for the Company’s ADDS initiatives. As of 31st March, 2011, LBC had successfully completed 68 full studies.